Edition:
United States

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

27.55USD
16 Jan 2018
Change (% chg)

-- (--)
Prev Close
$27.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
99,267
52-wk High
$30.85
52-wk Low
$11.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.020
Jun '17 0.00 -0.938
Mar '17 0.00 -0.883
FY 2016 Dec '16 0.00 -0.631
Sep '16 0.00 -0.881
Jun '16 0.00 -0.659
Mar '16 0.00 -0.580
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 1.30 6.50 0.00 15.05
Earnings (per share)
Quarter Ending Mar-18 4 -1.10 -1.05 -1.19 -0.96
Quarter Ending Jun-18 4 -1.13 -1.04 -1.30 -0.82
Year Ending Dec-18 6 -4.66 -4.17 -5.41 -4.15
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 203.19 37.36
P/E High - Last 5 Yrs. -- 267.52 45.49
P/E Low - Last 5 Yrs. -- 91.63 24.32
Beta -- 0.81 0.88
Price to Sales (TTM) -- 138.84 6.57
Price to Book (MRQ) 4.09 26.92 5.93
Price to Tangible Book (MRQ) 4.09 32.31 7.54
Price to Cash Flow (TTM) -- 115.99 25.80
% Owned Institutions -- 7.87 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.43
Dividend Yield - 5 Year Avg -- 0.24 2.04
Dividend 5 Year Growth Rate -- 1.88 5.28
Payout Ratio(TTM) -- 87.92 45.92

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -6.95 6.75
Sales (TTM) vs TTM 1 Yr. Ago -- 29.75 6.89
Sales - 5 Yr. Growth Rate -- 33.16 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -15.83 -144.55 7.79
EPS (TTM) vs TTM 1 Yr. Ago -21.10 -- --
EPS - 5 Yr. Growth Rate -- 44.13 11.08
Capital Spending - 5 Yr. Growth Rate -- 40.78 15.22

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.56
Current Ratio (MRQ) 12.49 5.93 3.58
LT Debt to Equity (MRQ) 0.00 18.91 13.72
Total Debt to Equity (MRQ) 0.00 21.55 19.71
Interest Coverage (TTM) -- -137.11 35.32

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.18 54.88
Gross Margin - 5 Yr. Avg. -- 56.57 52.53
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -200.69 15.53
Operating Margin (TTM) -- -611.62 6.09
Operating Margin - 5 Yr. Avg. -- -219.14 10.83
Pre-Tax Margin (TTM) -- -581.62 6.96
Pre-Tax Margin - 5 Yr. Avg. -- -221.00 11.23
Net Profit Margin (TTM) -- -580.09 3.19
Net Profit Margin - 5 Yr. Avg. -- -224.64 7.51
Effective Tax Rate (TTM) -- 15.42 24.23
Effective Tax Rate - 5 Yr. Avg. -- 18.50 24.05

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,217,787 851,775,114
Net Income/Employee (TTM) -1,066,802 -2,114,756 99,621,228
Receivable Turnover (TTM) -- 27.39 6.17
Inventory Turnover (TTM) -- 2.85 3.53
Asset Turnover (TTM) 0.00 0.51 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.84 -5.53 11.35
Return on Assets - 5 Yr. Avg. -- 0.67 12.30
Return on Investment (TTM) -42.33 -7.35 14.44
Return on Investment - 5 Yr. Avg. -- 3.49 16.09
Return on Equity (TTM) -43.02 -29.01 16.10
Return on Equity - 5 Yr. Avg. -- 6.64 17.33
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Atara Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 83.67 77.39 97 85
13 Week 89.35 74.54 92 90
26 Week 73.82 54.05 87 77
52 Week 86.15 52.51 84 64
YTD 52.21 46.57 95 88
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 126
Total Shares Held: 34,944,704
3 Mo. Net Change: 1,975,203
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 8
# Reduced Positions: 2
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.